story book

Image via Ana/Flickr

Weighing in at a colossal 999 pages, the 21st Century Cures Act isn’t the most lightweight read out there. Luckily the commentary on the many ins, outs, and intricacies of the bill is extensive and detailed, and you can find our regularly update round up here. And for some more digestible Friday reading, here are some of the top stories from the world of science.

UK moves closer to allowing ‘three-parent’ babies

The UK may soon become the first country to explicitly permit the birth of children from embryos created using mitochondrial replacement therapy. The procedure was legalised in 2015, but the UK regulator has asked for more research before allowing clinical trials. The procedure has already been performed in Mexico and the Ukraine, which do not have regulation preventing it. Some researchers have argued that this development makes approval in the UK all the more urgent.

As the world’s top blood experts gather, 5 key questions to watch

As the world’s experts on all things blood gather in San Diego for the meeting of the American Society of Hematology, STAT News outlines five key questions that they’ll be seeking answers to at the event, including the safety of CAR-T immunotherapies, progress against sickle-cell anaemia, and care for lymphoma.

Artificial intelligence could dig up cures buried online

2.5 million scientific papers are published every year, and keeping on top of the deluge of information is almost impossible for healthcare professionals. But some have suggested that there could be a critical role for artificial intelligence systems that could read incoming papers, distill their information, and highlight relevant findings for doctors. 

Maryland congressman in running to head NIH?

Representative Andy Harris (R–MD), an anesthesiologist who has shown a keen interest in the National Institutes of Health (NIH) while in Congress, has put his hat in the ring for NIH director, according to Science. Harris says he knows that some biomedical scientists would view him as a controversial choice, but argues that his blend of research and political experience would make him a good advocate for addressing NIH’s flaws and for growing the agency’s budget in a time of fiscal restraint.

And one from us…

21st Century Cures: Future of healthcare or a bad deal for patients?

Reactions to the House vote on the 21st Century Cures Act have been a mixture of ecstatic and cautious. Here, we’re rounding up all the current commentary on the passage of the Cures Act, from both sides of the spectrum.